Avanos Medical AVNS Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 50%-4.6pp | 50.5%-5.0pp | 52.3%-3.2pp | 53.8%-2.0pp | 54.6%-1.7pp | |
| Operating margin | -9.1%+47.4pp | -9.1%+48.5pp | -69%-73.9pp | -68%-71.3pp | -56.6%-58.7pp | |
| Net margin | -10.4%+45.4pp | -10.4%+46.6pp | -67%— | -66.9%— | -55.8%— | |
| Returns | ||||||
| Return on equity | -9.2%+28.0pp | -9.1%+28.9pp | -46.7%— | -46.4%— | -37.2%— | |
| Return on invested capital | -7.5%+27.1pp | -7.5%+27.7pp | -44.2%-46.6pp | -43.4%-45.0pp | -34.7%-35.7pp | |
| Efficiency | ||||||
| Asset turnover | 0.7×+0.2× | 0.6×+0.1× | 0.5×+0.1× | 0.5×+0.1× | 0.5×+0.1× | |
| Liquidity | ||||||
| Current ratio | 2.5×-0.1× | 2.2×-0.2× | 2.4×+0.2× | 2.6×+0.4× | 2.6×+0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | |
| Per Share | ||||||
| Book value per share | $16.47-8.2% | $16.81-6.7% | $16.77-36.5% | $16.77-36.5% | $17.94-31.8% | |
| Valuation | ||||||
| Market capitalization | $1.17B+108% | $521.28M-28.8% | $536.41M-51.4% | $572.5M-37.4% | $659.23M-28.3% | |
| Price / sales | 1.6×+0.8× | 0.7×-0.3× | 0.8×-0.9× | 0.8×-0.5× | 1×-0.4× | |
| Price / book | 1.5×+0.8× | 0.7×-0.2× | 0.7×-0.2× | 0.7×0.0× | 0.8×0.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Avanos Medical's profit margins?
- Avanos Medical (AVNS) runs a 50.0% gross margin and a -9.1% operating margin, with a -10.4% net margin.
- Where do Avanos Medical's ratios come from?
- Every ratio is computed from Avanos Medical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
